The molecular mechanisms that shape the gene expression landscape during the development 35 and maintenance of chronic states of brain hyperexcitability are incompletely understood. 36 Here we show that cytoplasmic mRNA polyadenylation, a posttranscriptional mechanism for 37 regulating gene expression, undergoes widespread reorganisation in temporal lobe epilepsy. 38 Specifically, over 25% of the hippocampal transcriptome displayed changes in their poly(A) 39 tail in mouse models of epilepsy, particular evident in the chronic phase. The expression of 40 cytoplasmic polyadenylation binding proteins (CPEB1-4) was found to be altered in the 41 hippocampus in mouse models of epilepsy and temporal lobe epilepsy patients and CPEB4 42 target transcripts were over-represented among those showing poly(A) tail changes. 43 Supporting an adaptive function, CPEB4-deficiency leads to an increase in seizure severity 44 and neurodegeneration in mouse models of epilepsy. Together, these findings reveal an 45 additional layer of gene expression control during epilepsy and point to novel targets for 46 seizure control and disease-modification in epilepsy. 47 48 49 50 51 52 53 54 55 56 57 58 59 Epilepsy is one of the most common chronic neurological disorders, affecting approximately 60 70 million people worldwide 1,2 . Temporal lobe epilepsy (TLE) is the most common 61 refractory form of epilepsy in adults and typically results from an earlier precipitating insult 62 that causes structural and functional reorganisation of neuronal-glial networks within the 63 hippocampus resulting in chronic hyperexcitability 3 . These network changes, which include 64 selective neuronal loss, gliosis and synaptic remodelling, are driven in part by large-scale 65 changes in gene expression 4-7 . The gene expression landscape continues to be dysregulated 66 once epilepsy is established 8 . 67 Recent studies have uncovered important roles for post-transcriptional mechanisms during 68 the development of epilepsy. These include the actions of small noncoding RNA, such as 69 microRNA and post-translational control of protein turnover via the proteasome contributing 70
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deadenylation leads to reduced protein expression. This included the Glutamate ionotropic 139 receptor NMDA type subunit 2B (GRIN2B), previously shown to play a role during 140 epilepsy 26 , Syntaxin 6 (STX6) and N6-adenosine-methyltransferase (METTL3), genes not 141 associated with epilepsy before (Fig. 1c ). No significant changes in transcript levels of our 142 selected genes was observed when analysed post-status epilepticus, further suggesting this 143 decrease in expression is due to mRNA deadenylation (Fig. 1d) . Previous in vivo studies 144 showed that deadenylation, by resulting in decreased protein output, is more disruptive than 145 poly(A) tail elongation in the brain 21 . Our results therefore indicate that deadenylation may 155 To identify possible candidate RNA Binding Proteins (RNABPs) responsible for driving 156 seizure-induced alterations in poly(A) tail length, we first compiled a list of genes whose observed. Interestingly, increased transcription of Cpeb4 was most evident in the dentate 184 gyrus (Extended Data Fig. 3a ), a subfield of the hippocampus largely resistant to seizure-185 induced neuronal death in the model 24 . CPEB4 protein was also upregulated in the 186 hippocampus following status epilepticus induced by the cholinergic mimetic pilocarpine 187 (Extended Data Fig. 3b ), another widely used epilepsy model 32 . To provide additional proof 188 of a role for CPEBs during epilepsy, we analyzed epilepsy-related genes within targets of 189 CPEB1 and CPEB4 ( Supplementary Table 2 ). Notably, only CPEB4 binders were enriched 190 within epilepsy-related genes, further suggesting that CPEB4 is an important regulatory 191 protein during epilepsy ( Fig. 3c ).
Increased expression of CPEBs in the hippocampus of TLE patients

192
In summary, our data show altered expression of CPEBs in the hippocampus following status Next, to obtain functional evidence that CPEB4 is responsible for changes in mRNA 198 polyadenylation occurring during epilepsy, we compared our identified global poly(A) profile 199 following status epilepticus and during epilepsy to the poly(A) profile present in CPEB4 200 knock-out (KO) mice 21 . Notably, analysis of the global transcript polyadenylation status in CPEB4 deficiency increases seizure susceptibility and seizure-induced brain damage 209 To determine whether mRNA polyadenylation and CPEB4 contribute to brain excitability or 210 the pathophysiology of status epilepticus, we characterized seizures and their 211 neuropathological sequelae in CPEB4 heterozygous (CPEB4 KO/+ ) and homozygous 212 (CPEB4 KO/KO ) knockout mice 33 . Immunoblot and transcript analysis confirmed a partial and 213 full reduction of CPEB4 protein in the hippocampus of heterozygous and homozygous mice, 214 respectively (Extended Data Fig. 4a ). CPEB4-deficient mice also showed normal levels of 215 different cell-type markers and kainate receptor levels in the hippocampus (Extended Data 216 Fig. 4b ). Furthermore, hippocampal mRNA levels of the neuronal activity-regulated gene c- 217 Fos and baseline EEG recordings were similar between wildtype (WT), CPEB4 KO/+ and 218 CPEB4 KO/KO mice suggesting loss of CPEB4 does not noticeably alter normal brain function 219 (Extended Data Fig. 4c, d) . 220 We then investigated the impact of CPEB4-deficiency on status epilepticus triggered by an 
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Analysis of high frequency high amplitude (HFHA) paroxysmal discharges which correlate 228 with seizure-induced brain pathology 34 , revealed that both CPEB4 KO/+ and CPEB4 KO/KO mice 229 showed longer durations of HFHA spiking ( Fig. 5d ). Behavioral seizures were also more 230 severe in CPEB4 KO/+ and CPEB4 KO/KO mice during status epilepticus ( Fig. 5e ). Next, we 231 analysed brain sections to determine whether loss of CPEB4 affects neuropathological hippocampus and in the cortex (Fig. 5f, g) . 237 We also investigated neuropathological outcomes in a second model. CPEB4 KO/+ mice 238 subjected to status epilepticus induced by intraperitoneal pilocarpine showed increased 239 mortality (Extended data Fig. 5a ) and underwent more severe seizures (Extended data Fig.   240 5b, c), including longer durations of HFHA spiking (Extended data Fig. 5d ). Analysis of 241 brain sections from these mice also identified more neurodegeneration in the hippocampus 242 and cortex of CPEB4 KO/+ mice compared to WT controls (Extended data Fig. 5e ).
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Together, our results demonstrate that loss of CPEB4 increases vulnerability to seizures and 244 hippocampal damage indicating that CPEB4 is an important regulator of brain excitability 245 and seizure-induced neurodegeneration. together with the alteration of CPEBs in samples from human TLE and KA mouse models. 253 We further identify CPEB4 as a key neuroprotective regulator of mRNA polyadenylation 254 during epilepsy, and this is corroborated in CPEB4-deficient mice. among the various CPEBs, we show here that CPEB4 is a key player in epilepsy related poly(A)-dependent gene regulation, but we cannot discard that other CPEBs also play a role.
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The strongest evidence suggesting a role for CPEB4 include its early increase in expression 285 following acute seizures in two mouse models of status epilepticus and that a polyadenylation 286 profile opposite to the one observed during epilepsy is observed in CPEB4 knock-out mice.
287
Our data indicate that CPEB4 induction during epileptogenesis is neuroprotective and that the 288 high levels of expression found in human TLE patient tissue most likely represent an 289 endogenous antiepileptogenic adaptive mechanism to protect the brain once pathological 290 processes are initiated. Accordingly, CPEB4 deficiency in mice, despite having no apparent 291 impact on normal brain physiology 41 , lowers the seizure threshold upon challenge with 292 proconvulsants and leads to an increase in seizure severity and resulting brain damage. 
